Collagen-derived peptide coat |
Human umbilical vein endothelial cell; human aortic endothelial cell |
PGI2, vWF; PECAM-1, VE-Cadherin, NOS3, TM, E-selectin; |
Increase in NOS3 compared to TCPS; No significant change in PGI2, vWF; PECAM-1, VE-Cadherin, TM, E-selectin49
|
Crosslinked collagen coat |
Human umbilical vein endothelial cell; human saphenous vein |
PGI2, vWF, tPA, PAI-1 |
Decrease in PGI2 and vWF secretion; No difference in basal levels of PGI2, tPA increase compared to bare53, 165
|
ePTFE with collagen-1 coat |
Human saphenous vein; human umbilical vein |
tPA, PGI2, PAI-1 |
Decrease in PGI2 and tPA; no difference in tPA secretion; PAI increased; Different levels of PGI2, PAI-1 and tPA between unmodified versus modified PTFE53, 96, 175
|
Collagen derived peptide hydrogel (PEG-Scl2) |
Human aortic endothelial cell |
PECAM-1, VE-Cadherin, NOS3, TM, E-selectin |
Decrease in NOS3 and TM on PEG-Scl2 and E-selectin increased compared to collagen; no significant change in PECAM-1112
|